Early Response to Antipsychotic Drug Therapy as a Clinical Marker of Subsequent Response in the Treatment of Schizophrenia

Long-Term Improvement in Efficacy and Safety After Switching to Ziprasidone in Stable Outpatients with Schizophrenia

(2016) George M. Simpson et al.   CNS SPECTRUMS

Metabolic Risk with Second-Generation Antipsychotic Treatment: A Double-Blind Randomized 8-Week Trial of Risperidone and Olanzapine

(2011) Deanna L. Kelly et al.   Annals of Clinical Psychiatry

A Double-Blind, Randomized Comparative Study of Aripiprazole and Olanzapine in Patients with Schizophrenia

(2008) W. Wolfgang Fleischhacker et al.   BIOLOGICAL PSYCHIATRY

Assessment of strategies for switching patients from olanzapine to risperidone: A randomized, open-label, rater-blinded study

(2008) Rohan Ganguli et al.   BMC Medicine

Switching from risperidone to olanzapine in a one-year, randomized, open-label effectiveness study of schizophrenia

(2008) Douglas E. Faries et al.   CURRENT MEDICAL RESEARCH AND OPINION

Limitations of current therapies: Why do patients switch therapies?

(2008) Peter Falkai   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Effect of risperidone and olanzapine on reproductive hormones, psychopathology and sexual functioning in male patients with schizophrenia

(2008) Beata Konarzewska et al.   PSYCHONEUROENDOCRINOLOGY

Predicting antipsychotic drug response – Replication and extension to six weeks in an international olanzapine study

(2008) Stefan Leucht et al.   SCHIZOPHRENIA RESEARCH

Impact of antipsychotic treatment on nonfasting triglycerides in the CATIE Schizophrenia Trial phase 1

(2008) Jonathan M. Meyer et al.   SCHIZOPHRENIA RESEARCH

Predicting response to atypical antipsychotics based on early response in the treatment of schizophrenia☆

(2008) B KINON et al.   SCHIZOPHRENIA RESEARCH

Does switching to a new antipsychotic improve outcomes?

(2008) Robert A Rosenheck et al.   SCHIZOPHRENIA RESEARCH

Clinical, Functional, and Economic Ramifications of Early Nonresponse to Antipsychotics in the Naturalistic Treatment of Schizophrenia

(2007) H. Ascher-Svanum et al.   SCHIZOPHRENIA BULLETIN